Through western blotting, we found that there was negative correlation between the expression of ACAT1 and that of FUS in four common prostate cancer cell lines (LNCaP, PC3, DU145, and 22RV1) (Fig. S2A,R = -0.9148). Here, FUS is linked to prostate carcinoma.